Literature DB >> 31128829

The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety Datalink.

Chengyi Zheng1, Wei Yu2, Fagen Xie2, Wansu Chen2, Cheryl Mercado2, Lina S Sy2, Lei Qian2, Sungching Glenn2, Gina Lee2, Hung Fu Tseng2, Jonathan Duffy3, Lisa A Jackson4, Matthew F Daley5, Brad Crane6, Huong Q McLean7, Steven J Jacobsen2.   

Abstract

OBJECTIVE: Local reactions are the most common vaccine-related adverse event. There is no specific diagnosis code for local reaction due to vaccination. Previous vaccine safety studies used non-specific diagnosis codes to identify potential local reaction cases and confirmed the cases through manual chart review. In this study, a natural language processing (NLP) algorithm was developed to identify local reaction associated with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in the Vaccine Safety Datalink.
METHODS: Presumptive cases of local reactions were identified among members ≥ 11 years of age using ICD-9-CM codes in all care settings in the 1-6 days following a Tdap vaccination between 2012 and 2014. The clinical notes were searched for signs and symptoms consistent with local reaction. Information on the timing and the location of a sign or symptom was also extracted to help determine whether or not the sign or symptom was vaccine related. Reactions triggered by causes other than Tdap vaccination were excluded. The NLP algorithm was developed at the lead study site and validated on a stratified random sample of 500 patients from five institutions.
RESULTS: The NLP algorithm achieved an overall weighted sensitivity of 87.9%, specificity of 92.8%, positive predictive value of 82.7%, and negative predictive value of 95.1%. In addition, using data at one site, the NLP algorithm identified 3326 potential Tdap-related local reactions that were not identified through diagnosis codes.
CONCLUSION: The NLP algorithm achieved high accuracy, and demonstrated the potential of NLP to reduce the efforts of manual chart review in vaccine safety studies.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical notes; Electronic health record; Natural language processing; Vaccine adverse event; Vaccine safety

Mesh:

Substances:

Year:  2019        PMID: 31128829      PMCID: PMC6645678          DOI: 10.1016/j.ijmedinf.2019.04.009

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  39 in total

1.  White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink.

Authors:  Jason M Glanz; Sophia R Newcomer; Michael L Jackson; Saad B Omer; Robert A Bednarczyk; Jo Ann Shoup; Frank DeStefano; Matthew F Daley
Journal:  Vaccine       Date:  2016-02-15       Impact factor: 3.641

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study.

Authors:  Lisa A Jackson; Onchee Yu; Jennifer Nelson; Edward A Belongia; Simon J Hambidge; Roger Baxter; Allison Naleway; James Nordin; James Baggs; John Iskander
Journal:  Vaccine       Date:  2009-06-28       Impact factor: 3.641

4.  Injection site and risk of medically attended local reactions to acellular pertussis vaccine.

Authors:  Lisa A Jackson; Onchee Yu; Jennifer C Nelson; Clara Dominguez; Do Peterson; Roger Baxter; Simon J Hambidge; Allison L Naleway; Edward A Belongia; James D Nordin; James Baggs
Journal:  Pediatrics       Date:  2011-02-07       Impact factor: 7.124

5.  Document-level classification of CT pulmonary angiography reports based on an extension of the ConText algorithm.

Authors:  Brian E Chapman; Sean Lee; Hyunseok Peter Kang; Wendy W Chapman
Journal:  J Biomed Inform       Date:  2011-04-01       Impact factor: 6.317

Review 6.  Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012.

Authors:  Heidi J Larson; Caitlin Jarrett; Elisabeth Eckersberger; David M D Smith; Pauline Paterson
Journal:  Vaccine       Date:  2014-03-02       Impact factor: 3.641

Review 7.  Natural language processing in biomedicine: a unified system architecture overview.

Authors:  Son Doan; Mike Conway; Tu Minh Phuong; Lucila Ohno-Machado
Journal:  Methods Mol Biol       Date:  2014

8.  Diagnostic tests 2: Predictive values.

Authors:  D G Altman; J M Bland
Journal:  BMJ       Date:  1994-07-09

Review 9.  Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

Authors:  Tom T Shimabukuro; Michael Nguyen; David Martin; Frank DeStefano
Journal:  Vaccine       Date:  2015-07-22       Impact factor: 3.641

10.  The incident reporting system does not detect adverse drug events: a problem for quality improvement.

Authors:  D J Cullen; D W Bates; S D Small; J B Cooper; A R Nemeskal; L L Leape
Journal:  Jt Comm J Qual Improv       Date:  1995-10
View more
  7 in total

1.  Risk for Shoulder Conditions After Vaccination: A Population-Based Study Using Real-World Data.

Authors:  Chengyi Zheng; Jonathan Duffy; In-Lu Amy Liu; Lina S Sy; Wansu Chen; Lei Qian; Ronald A Navarro; Denison S Ryan; Sunhea S Kim; Cheryl Mercado; Steven J Jacobsen
Journal:  Ann Intern Med       Date:  2022-03-22       Impact factor: 25.391

2.  Identifying Cases of Shoulder Injury Related to Vaccine Administration (SIRVA) in the United States: Development and Validation of a Natural Language Processing Method.

Authors:  Chengyi Zheng; Jonathan Duffy; In-Lu Amy Liu; Lina S Sy; Ronald A Navarro; Sunhea S Kim; Denison S Ryan; Wansu Chen; Lei Qian; Cheryl Mercado; Steven J Jacobsen
Journal:  JMIR Public Health Surveill       Date:  2022-05-24

3.  Automated Identification and Extraction of Exercise Treadmill Test Results.

Authors:  Chengyi Zheng; Benjamin C Sun; Yi-Lin Wu; Ming-Sum Lee; Ernest Shen; Rita F Redberg; Maros Ferencik; Shaw Natsui; Aniket A Kawatkar; Visanee V Musigdilok; Adam L Sharp
Journal:  J Am Heart Assoc       Date:  2020-02-21       Impact factor: 5.501

Review 4.  Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development.

Authors:  Arash Keshavarzi Arshadi; Julia Webb; Milad Salem; Emmanuel Cruz; Stacie Calad-Thomson; Niloofar Ghadirian; Jennifer Collins; Elena Diez-Cecilia; Brendan Kelly; Hani Goodarzi; Jiann Shiun Yuan
Journal:  Front Artif Intell       Date:  2020-08-18

5.  The Food and Drug Administration Biologics Effectiveness and Safety Initiative Facilitates Detection of Vaccine Administrations From Unstructured Data in Medical Records Through Natural Language Processing.

Authors:  Matthew Deady; Hussein Ezzeldin; Kerry Cook; Douglas Billings; Jeno Pizarro; Amalia A Plotogea; Patrick Saunders-Hastings; Artur Belov; Barbee I Whitaker; Steven A Anderson
Journal:  Front Digit Health       Date:  2021-12-22

6.  Identification of Preterm Labor Evaluation Visits and Extraction of Cervical Length Measures from Electronic Health Records Within a Large Integrated Health Care System: Algorithm Development and Validation.

Authors:  Fagen Xie; Nehaa Khadka; Michael J Fassett; Vicki Y Chiu; Chantal C Avila; Jiaxiao Shi; Meiyu Yeh; Aniket Kawatkar; Nana A Mensah; David A Sacks; Darios Getahun
Journal:  JMIR Med Inform       Date:  2022-09-06

7.  The use of natural language processing to identify vaccine-related anaphylaxis at five health care systems in the Vaccine Safety Datalink.

Authors:  Wei Yu; Chengyi Zheng; Fagen Xie; Wansu Chen; Cheryl Mercado; Lina S Sy; Lei Qian; Sungching Glenn; Hung F Tseng; Gina Lee; Jonathan Duffy; Michael M McNeil; Matthew F Daley; Brad Crane; Huong Q McLean; Lisa A Jackson; Steven J Jacobsen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-12-03       Impact factor: 2.732

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.